Sathler-Avelar, R <br/><br/>
Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.  [electronic resource] 

 -  Scandinavian journal of immunology  Nov 2006 
 - 554-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-9475 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-3083.2006.01843.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Animals<br/>Case-Control Studies<br/>Chagas Disease--immunology<br/>Child<br/>Cytokines--blood<br/>Female<br/>Gene Expression<br/>Humans<br/>Immunity, Innate<br/>Longitudinal Studies<br/>Male<br/>Nitroimidazoles--therapeutic use<br/>Trypanosoma cruzi--immunology